Drugs / Loteprendol etabonate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02825186 | Jul 2016 → Jun 2018 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Loteprendol etabonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02825186 ↗ |
| Known as | Lotemax | “Loteprendol etabonate 0.5% (Lotemax)” NCT02825186 ↗ |
| Route | Topical | “Topical Loteprendol used after strabismus surgery” NCT02825186 ↗ |